Inspire Medical Systems Inc (INSP) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Inspire Medical Systems Inc (INSP) has a cash flow conversion efficiency ratio of 0.028x as of June 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($23.23 Million) by net assets ($825.58 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see Inspire Medical Systems Inc (INSP) market capitalisation for the company's overall valuation and market capitalisation.
Inspire Medical Systems Inc - Cash Flow Conversion Efficiency Trend (2016–2025)
This chart illustrates how Inspire Medical Systems Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Inspire Medical Systems Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Inspire Medical Systems Inc ranked by their cash flow conversion efficiency. Explore Inspire Medical Systems Inc (INSP) cash flow quality to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Graubuendner Kantonalbank
SW:GRKP
|
0.045x |
|
Beijing Yuanliu Hongyuan Electronic Technology Co Ltd
SHG:603267
|
-0.030x |
|
DTR Automotive
KO:007340
|
0.068x |
|
Sichuan Anning Iron and Titanium Co
SHE:002978
|
-0.068x |
|
Yankershop Food Co Ltd
SHE:002847
|
0.153x |
|
The Jammu & Kashmir Bank Limited
NSE:J&KBANK
|
-0.278x |
|
Carabao Group Public Company Limited
BK:CBG
|
0.036x |
|
S&T Bancorp Inc
NASDAQ:STBA
|
0.020x |
Annual Cash Flow Conversion Efficiency for Inspire Medical Systems Inc (2016–2025)
The table below shows the annual cash flow conversion efficiency of Inspire Medical Systems Inc from 2016 to 2025. View INSP stock price and chart for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | $781.16 Million | $116.98 Million | 0.150x | -20.70% |
| 2024-12-31 | $689.70 Million | $130.25 Million | 0.189x | +338.55% |
| 2023-12-31 | $572.51 Million | $24.65 Million | 0.043x | +84.62% |
| 2022-12-31 | $496.01 Million | $11.57 Million | 0.023x | +126.55% |
| 2021-12-31 | $229.05 Million | $-20.12 Million | -0.088x | +61.96% |
| 2020-12-31 | $229.75 Million | $-53.05 Million | -0.231x | +3.27% |
| 2019-12-31 | $139.84 Million | $-33.38 Million | -0.239x | -109.40% |
| 2018-12-31 | $164.00 Million | $-18.69 Million | -0.114x | +98.93% |
| 2017-12-31 | $1.48 Million | $-15.79 Million | -10.641x | -491.75% |
| 2016-12-31 | $-6.61 Million | $-17.95 Million | 2.716x | -- |
About Inspire Medical Systems Inc
Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for patients with moderate to severe OSA. It also develop… Read more